High estradiol levels during a long agonist IVF protocol are associated with decreased food intake, higher leptin concentrations, and lower levels of high-sensitivity C-reactive protein.


Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
09 2023
Historique:
received: 25 11 2022
accepted: 24 01 2023
medline: 17 7 2023
pubmed: 17 2 2023
entrez: 16 2 2023
Statut: ppublish

Résumé

To study whether different hormonal phases affect appetite regulation, food intake, and concentrations of leptin, glucagon-like peptide-1 (GLP-1), and high-sensitivity C-reactive protein (hs-CRP) during a long agonist in vitro fertilization (IVF) protocol. Fifty-four infertile women were encountered thrice, the first of which was at the beginning of their period (low estradiol). The other two visits were during a gonadotrophin-releasing hormone (GnRH) analog downregulation (low estradiol) and at the end of a follicle-stimulating hormone (FSH) stimulation (high estradiol). The first visit was the reference; the women served as their controls. The concentrations of leptin, GLP-1, and hs-CRP were assessed from plasma. Dietary intake was assessed using food records (FRs). In addition, weight, height, body mass index (BMI), and plasma levels of estradiol, glucose, HbA1c, insulin, and lipids were monitored. Twenty-six of the subjects also had a postprandial test. During the stimulation protocol, leptin concentrations elevated (P < 0.001), and energy intake decreased (P = 0.03), while estradiol levels increased (P < 0.001). GLP-1 levels unchanged (P = 0.75) and hs-CRP (P = 0.03) concentrations diminished, while estradiol levels increased. No increased food intake or weight gain occurred during the stimulation protocol; thus, leptin may protect from overeating during high estradiol levels, and leptin resistance may not occur during a short follow-up. Also, a favorable anti-inflammatory effect was detected. During this study, we observed no harmful metabolic effects, which might affect negatively maternal health.

Identifiants

pubmed: 36797524
doi: 10.1007/s00404-023-06950-9
pii: 10.1007/s00404-023-06950-9
pmc: PMC10348986
doi:

Substances chimiques

Leptin 0
C-Reactive Protein 9007-41-4
Gonadal Steroid Hormones 0
Follicle Stimulating Hormone 9002-68-0
Estradiol 4TI98Z838E
Glucagon-Like Peptide 1 89750-14-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

883-891

Informations de copyright

© 2023. The Author(s).

Références

J Reprod Immunol. 2021 Nov;148:103434
pubmed: 34688101
Gynecol Endocrinol. 2012 Jun;28(6):418-21
pubmed: 22115073
Hum Reprod. 2012 Jun;27(6):1822-8
pubmed: 22422777
Int J Womens Health. 2021 May 10;13:445-458
pubmed: 34007218
Am J Physiol Gastrointest Liver Physiol. 2009 Sep;297(3):G602-10
pubmed: 19556358
Endocr J. 2009;56(3):425-33
pubmed: 19225215
J Reprod Immunol. 2012 Dec;96(1-2):58-67
pubmed: 22981121
Hum Reprod. 2004 Feb;19(2):357-9
pubmed: 14747180
J Assist Reprod Genet. 2008 Aug;25(8):383-8
pubmed: 18810632
Hum Reprod Update. 2014 Mar-Apr;20(2):153-74
pubmed: 24173881
Int J Obes (Lond). 2016 Apr;40(4):622-32
pubmed: 26499438
Brain Res. 2010 Dec 10;1364:198-215
pubmed: 20869351
Physiol Behav. 1995 Dec;58(6):1067-77
pubmed: 8623004
Maturitas. 2012 Mar;71(3):248-56
pubmed: 22281161
Br J Nutr. 2005 Jun;93(6):845-51
pubmed: 16022753
J Nutr. 2015 Apr;145(4):672-80
pubmed: 25833771
Hum Reprod Update. 2010 May-Jun;16(3):276-92
pubmed: 19926661
Philos Trans R Soc Lond B Biol Sci. 2006 Jul 29;361(1471):1251-63
pubmed: 16815802
Metab Syndr Relat Disord. 2020 Nov;18(9):399-405
pubmed: 32876506
Neurosci Biobehav Rev. 1992 Summer;16(2):235-72
pubmed: 1630733
Int J Obes (Lond). 2009 Apr;33(4):456-64
pubmed: 19238154
Fertil Steril. 2012 Sep;98(3):664-670.e2
pubmed: 22704632
Hum Reprod. 1997 Jun;12(6):1142-51
pubmed: 9221991
Reprod Biol Endocrinol. 2020 May 12;18(1):44
pubmed: 32398163
Hypertension. 2017 Nov;70(5):1057-1064
pubmed: 28923899
J Pediatr Endocrinol Metab. 2019 Jan 28;32(1):27-31
pubmed: 30530892
J Endocrinol. 2019 Nov 1;244(1):R1-R15
pubmed: 31751295
Metabolism. 2013 Apr;62(4):457-78
pubmed: 22999785
J Neuroendocrinol. 2010 Jul;22(7):805-17
pubmed: 20456605

Auteurs

Jonna Leppänen (J)

Department of Obstetrics and Gynecology, Kuopio University Hospital and University of Eastern Finland, Puijonlaaksontie 2, 70210, Kuopio, Finland. jonna.leppanen@kuh.fi.

Petrus Nuotio (P)

Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, P.O. Box 1627, 70211, Kuopio, Finland.

Kaisa Randell (K)

Pihlajalinna Dextra Fertility Clinic, Helsinki, Finland.

Jarkko Romppanen (J)

Eastern Finland Laboratory Centre, Puijonlaaksontie 2, 70210, Kuopio, Finland.

Leea Keski-Nisula (L)

Department of Obstetrics and Gynecology, Kuopio University Hospital and University of Eastern Finland, Puijonlaaksontie 2, 70210, Kuopio, Finland.

Tomi Laitinen (T)

Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland, Puijonlaaksontie 2, 70210, Kuopio, Finland.

Jussi Pihlajamäki (J)

Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, P.O. Box 1627, 70211, Kuopio, Finland.
Department of Medicine, Endocrinology and Clinical Nutrition, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland.

Ursula Schwab (U)

Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, P.O. Box 1627, 70211, Kuopio, Finland.
Department of Medicine, Endocrinology and Clinical Nutrition, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland.

Seppo Heinonen (S)

Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, PO Box 140, 00029, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH